Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Use of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treating Ulcerative Colitis in Patients

    Not recruiting

    1 1 1
    Investigated Diseases:
    Denmark
  • Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Slovakia
  • Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    Bulgaria Estonia Hungary Latvia Lithuania Poland +1
  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Drugs:
    Belgium Denmark France Italy Norway Poland +2
  • Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Croatia France Germany Italy +4
  • Study on Subcutaneous Infliximab for Patients with Ulcerative Colitis, Crohn’s Disease, or Unclassified Inflammatory Bowel Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium
  • Study on the Effects of Oxygen Therapy with Vedolizumab, Ustekinumab, or Infliximab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Poland
  • Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +6
  • Study on the Effectiveness and Safety of Subcutaneous Infliximab for Patients with Active Crohn’s Disease or Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France